HIV Curbside Consults, Volume IV: Treating the Patient Who Struggles With Adherence and Stigma

0.25 CME
15 MINS
$0 FEE
SAVE
HIV

Overview

Provider Statement

This continuing medical education activity is provided by National Jewish Health

Educational Partner: Vindico Medical Education


Support Statement

This activity is supported by an educational grant from ViiV Healthcare.


Activity Description

In this case-based video, Babafemi O. Taiwo, MBBS, and Jonathan A. Colasanti, MD, MSPH, discuss a patient with HIV diagnosed at 2 months of age, who has not been seen for his HIV infection in 2 years and is currently not receiving therapy.


Target Audience

The intended audience for the activity is infectious disease specialists and other health care professionals involved in the treatment of patients with HIV.


Learning Objective(s)

Upon successful completion of this educational activity, participants should be better able to:

  • Incorporate strategies for optimizing adherence to ART in patients with HIV.
  • Optimize the selection of HIV treatment regimens based on clinical efficacy and safety, potential for resistance, and individual patient characteristics.

Activity Co-Chairs

Richard A. Elion, MD
Director of Clinical Research
Washington Health Institute
Clinical Professor of Medicine
George Washington University School of Medicine
Washington, DC

Paul E. Sax, MD
Clinical Director, Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, MA


Faculty

Jonathan A. Colasanti, MD, MSPH
Assistant Professor of Medicine
Division of Infectious Diseases
Emory University
Atlanta, GA

Babafemi O. Taiwo, MBBS
Professor of Medicine
Chief, Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, IL


External Reviewer

Lisa Hightow-Weidman, MD, MPH


Accreditation

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

National Jewish Health designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, December 5, 2019 to December 4, 2020.


How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, watch the presentation, and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, National Jewish Health will issue an AMA PRA Category 1 Credit(s)™ certificate.


Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the past 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. 

Activity Co-Chairs and Faculty report the following relationship(s)

Jonathan A. Colasanti, MD, MSPH
No relevant financial relationships to disclose.

Richard A. Elion, MD
Consulting Fee: Gilead, ViiV
Speakers Bureau: Gilead, ViiV
Contracted Research: Gilead, Trio Health, ViiV

Paul E. Sax, MD
Consulting Fee: Gilead, GlaxoSmithKline/ViiV, Janssen, Merck
Contracted Research: Gilead, GlaxoSmithKline/ViiV, Merck
Editorial Positions: Medscape, NEJM Journal Watch, Open Forum Infectious Diseases, UpToDate

Babafemi O. Taiwo, MBBS
Consulting Fee: Gilead, GlaxoSmithKline, Merck, ViiV

External Reviewer report the following relationship(s):

Lisa Hightow-Weidman, MD, MPH
No relevant financial relationships to disclose. 

National Jewish Health and Vindico Medical Education staff report the following relationship(s)

Betti Bandura, ELS
No relevant financial relationships to disclose.

Mandy Comeau
No relevant financial relationships to disclose.

Stephanie Corder, ND, RN, CHCP
No relevant financial relationships to disclose.

Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.

Lynda Lyons
No relevant financial relationships to disclose.

Signed disclosures are on file at National Jewish Health and Vindico Medical Education.


Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.


Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-848-1000; Fax: 856-848-6091. Printed in the USA. Copyright © 2019 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education and National Jewish Health continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education and National Jewish Health. Neither Vindico Medical Education, National Jewish Health, nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.


CME Questions?

Contact us at cme@vindicoCME.com